MedTrace Logo

SaeboGlove Therapy for Severe Upper Limb Disability and Severe Hand Impairment After Stroke

NCT04007315 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2020-05-15

No results posted yet for this study

Summary

The study will aim to determine whether 6-weeks of using a SaeboGlove independently (with or without help from a carer) improves upper limb function (measured using the Action Research Arm Test score) in comparison to usual care alone in people with reduced active finger extension, severe upper limb disability and severe hand impairment after recent stroke.

Conditions

Interventions

DEVICE

SaeboGlove therapy

An individualised self-management training programme involving repetitive grasping and releasing movements over 6 weeks.

BEHAVIORAL

Usual care

6-weeks of usual NHS care

Sponsors & Collaborators

  • University of Glasgow

    collaborator OTHER

  • NHS Greater Glasgow and Clyde

    lead OTHER

Principal Investigators

  • Jesse Dawson, MD · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-21
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04007315 on ClinicalTrials.gov